<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:108px; width:501px; height:625px;"><span style="font-family: Arial,Bold; font-size:10px">Results</span><span style="font-family: Arial; font-size:10px">: IS and β-cell function decreased over 6-yrs by 14-24.3% (all p&lt;0.001; Fig. A-B); although 
<br>BMI or WC did not change (&lt;2%). Conversion to dysglycemia was ~12% over 6-yrs, where higher 
<br>total NEFA increased the risk by 25% (RR=1.25 (1.02-1.52) per SD). While total NEFA were not 
<br>associated with IS, palmitate predicted declines in HOMA-IS (p=0.037). Higher total NEFA predicted 
<br>declines in IGI/IR and ISSI-2 (both p&lt;0.02; Fig. C), with higher concentrations of palmitate, oleate, and 
<br>linoleate predicting declines in ISSI-2 (p=0.003 to 0.043); these three species comprised 74.8% of 
<br>total NEFA. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Conclusions</span><span style="font-family: Arial; font-size:10px">: Given that palmitate, oleate, and linoleate comprise the majority of the NEFA pool, our 
<br>findings suggest that </span><span style="font-family: Arial,Italic; font-size:10px">total</span><span style="font-family: Arial; font-size:10px"> NEFA rather than individual species may more strongly influence T2DM 
<br>risk, primarily through β-cell dysfunction. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Funding</span><span style="font-family: Arial; font-size:10px">: Canadian Institutes for Health Research, Canadian Diabetes Association, Banting and Best 
<br>Diabetes Center 
<br></span><span style="font-family: Arial; font-size:11px"> 
<br> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">Short Oral Abstract 15 –  Increase in angiotensin converting enzyme in 
<br>response to a high fat diet</span><span style="font-family: Arial; font-size:11px">  
<br></span><span style="font-family: Arial,Bold; font-size:11px">(Rita Schüler, Germany) 
<br></span><span style="font-family: Arial; font-size:11px"> 
<br></span><span style="font-family: Arial,Italic; font-size:10px">Rita Schüler</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">*, Martin A Osterhoff</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Turid Frahnow</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Anne-Cathrin Seltmann</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Stefan Kabisch</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Silke 
<br>Hornemann</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Michael Kruse</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Andreas FH Pfeiffer</span><span style="font-family: Arial,Italic; font-size:6px">1,2 
<br>1</span><span style="font-family: Arial,Italic; font-size:10px">German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Department of Clinical Nutrition, 
<br>Nuthetal, Germany; </span><span style="font-family: Arial,Italic; font-size:6px">2</span><span style="font-family: Arial,Italic; font-size:10px">Charité-University Medicine Berlin Campus Benjamin Franklin, Department of 
<br>Endocrinology, Diabetes and Nutrition, Berlin, Germany. 
<br></span><span style="font-family: Arial; font-size:10px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Objective: </span><span style="font-family: Arial; font-size:10px">In addition to an effective treatment in cardiovascular diseases, inhibition of angiotensin-
<br>converting enzyme (ACE) also improves insulin sensitivity. On the contrary, carriage of the D-allele of 
<br>the ACE insertion/deletion (I/D) polymorphism is associated with increased ACE serum levels and 
<br>impaired glucose tolerance. We aimed to investigate effects of a high-fat diet (HF) on ACE considering 
<br>possible nutrigenetic effects. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Methods:</span><span style="font-family: Arial; font-size:10px"> In the NUGAT (NUtriGenomic Analysis in Twins) study 46 healthy twin pairs went from a 6-
<br>week carbohydrate-rich low-fat diet (LF) to a 6-week HF diet under isocaloric conditions. Clinical 
<br>investigation days (CIDs) took place after 6 weeks LF and after 1 and 6 weeks of HF. At each CID 
<br>subcutaneous adipose tissue biopsies were taken for gene expression analysis on Agilent 8x60K 
<br>microarrays. Serum parameters were analyzed in blood samples using ELISA. To assess insulin 
<br>sensitivity intravenous glucose tolerance tests (ivGTT) were performed and incremental areas under 
<br>the curve (AUC) calculated. Genomic DNA extracted from whole blood was genotyped using Illumina 
<br>HumanOmniExpressExome BeadChips. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Results:</span><span style="font-family: Arial; font-size:10px"> After six weeks HF circulating ACE levels increased by 15% (HF6 161±49 ng/ml vs. LF 
<br></span><span style="font-family: Arial; font-size:10px">139±41 ng/ml; p&lt;0.001) paralleled by an increase in adipose tissue gene expression (1.41-fold, 
<br></span><span style="font-family: Arial; font-size:10px">p&lt;0.001). Interestingly, in homozygous carriers (GG) of the rs4343 polymorphism, which serves as a 
<br></span><span style="font-family: Arial; font-size:10px">surrogate marker for ACE I/D polymorphism, the increase in serum levels was nearly twice as high as 
<br></span><span style="font-family: Arial; font-size:10px">compared to non-carriers (AA) or heterozygous carriers (AG) (p&lt;0.001). Whereas no change in 
<br>glucose tolerance was observed for AA/AG-carriers, glucose tolerance significantly declined in GG-
<br>carriers after six weeks of HF (ΔAUC</span><span style="font-family: Arial; font-size:6px">glucose</span><span style="font-family: Arial; font-size:10px">, recessive model:</span><span style="font-family: Arial; font-size:6px"> </span><span style="font-family: Arial; font-size:10px">p=0.009).  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Conclusions: </span><span style="font-family: Arial; font-size:10px">ACE might constitute a molecular link between dietary fat intake and cardiovascular 
<br></span><span style="font-family: Arial; font-size:10px">diseases as well as impaired glucose metabolism. The extent of this relationship seems to be 
<br></span><span style="font-family: Arial; font-size:10px">nutrigenetically modulated.  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Protocol registration: </span><span style="font-family: Arial; font-size:10px">www.ClinicalTrials.gov, identifier NCT01631123</span><span style="font-family: Arial,Bold; font-size:10px"> 
<br>Funding Source: </span><span style="font-family: Arial; font-size:10px">German Federal Ministry of Education and Research (Grant No. 0315424)</span><span style="font-family: ABCDEE+Calibri; font-size:11px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:745px; width:9px; height:18px;"><span style="font-family: ABCDEE+MV Boli; font-size:18px"> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">63 
<br> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:200px; top:745px; width:9px; height:18px;"><span style="font-family: ABCDEE+MV Boli; font-size:18px"> 
<br></span></div><div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
